Sort
130,381 grants matching “hiv”
PREVENTION OF HIV INFECTION IN HEALTH CARE SETTINGS IN CAMEROON
$864,685Jean Bosco Nfetam Elat · National Aids Control Committee · U2G · FY2012 · PS
First-in-human study of a potent anti-HBsAg neutralizing antibody
$864,658Marina Caskey · Rockefeller University · U01 · FY2023 · AI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$864,620James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2012 · DK
Advanced Preclinical and Clinical Development and Regulatory Evaluations
$864,582Robert Walter Buckheit · Albert Einstein College Of Medicine · U19 · FY2011 · AI
Quantification of HIV burden and the biomedical, structural, and behavioral factors influencing HIV/AIDS among children and young adolescents
$864,572Hmwe Hmwe Kyu · University Of Washington · R01 · FY2025 · AI
PWID Opportunities to Improve TrEat and Retain (POINTER)
$864,464Gregory M Lucas · Johns Hopkins University · R01 · FY2020 · DA
Defining and then Maximizing the Footprint of CTL Selection on HIV Integration Site Landscapes to Optimize Cure Strategies
$864,325R. Brad Jones · Weill Medical Coll Of Cornell Univ · R37 · FY2024 · AI
Development of Novel Immunogens for Vaccines to HIV-1
$864,291Robert Gerald Whalen · Maxygen, Inc. · P01 · FY2007 · AI
Deciphering the impact of sex in early subtype C HIV infection and during HART
$864,286Eric Hunter · Emory University · R01 · FY2022 · AI
Center for Advancing Longtiudinal Drug Abuse Research
$864,192Yih-Ing Hser · University Of California Los Angeles · P30 · FY2011 · DA
Clinical Core
$864,157Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Cellular Immune Responses and AIDS Pathogenesis
$864,093Emory University · R01 · FY2004 · AI
B cell determinants of EBV latency
$864,001Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · CA
Positive Health Check Evaluation Trial Yr. 5
$863,976Megan A Lewis · Research Triangle Institute · U18 · FY2019 · PS
2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
$863,939Catherine A Spino · University Of Michigan At Ann Arbor · U24 · FY2021 · HL
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction
$863,930Lishomwa C Ndhlovu · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AG
NIDA Epidemiology Training Program
$863,890Renee M. Johnson · Johns Hopkins University · T32 · FY2016 · DA
Administrative Core
$863,772Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2018 · GM
SOUTH AFRICAN ADOLESCENT HEALTH PROMOTION PROJECT
$863,762John Barton Jemmott · University Of Pennsylvania · R01 · FY2006 · MH
How antigen exposure shapes the subsequent NK cell response to HIV
$863,699Silke Paust · Scripps Research Institute, The · R01 · FY2022 · AI
Elite controllers as a model for a cure of HIV-1 infection
$863,638Xu Yu · Massachusetts General Hospital · R37 · FY2024 · AI
Epigenetic HIV Silencing in Macrophages
$863,603Ronald G Collman · University Of Pennsylvania · R61 · FY2018 · AI
Epigenetic HIV Silencing in Macrophages
$863,500Ronald G Collman · University Of Pennsylvania · R33 · FY2021 · AI
High-Resolution Protein and Nucleic Acid Footprinting
$863,327Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Proteomics Core
$863,234S Munir Alam · Duke University · U19 · FY2011 · AI